SG11201807676UA - Method for protein purification - Google Patents

Method for protein purification

Info

Publication number
SG11201807676UA
SG11201807676UA SG11201807676UA SG11201807676UA SG11201807676UA SG 11201807676U A SG11201807676U A SG 11201807676UA SG 11201807676U A SG11201807676U A SG 11201807676UA SG 11201807676U A SG11201807676U A SG 11201807676UA SG 11201807676U A SG11201807676U A SG 11201807676UA
Authority
SG
Singapore
Prior art keywords
international
ucb
co7k
ipd
pct
Prior art date
Application number
SG11201807676UA
Other languages
English (en)
Inventor
Richard Jones
Jonathan Symmons
Saskia Hocking
Original Assignee
Ucb Biopharma Sprl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=58461345&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG11201807676U(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ucb Biopharma Sprl filed Critical Ucb Biopharma Sprl
Publication of SG11201807676UA publication Critical patent/SG11201807676UA/en

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/10—Selective adsorption, e.g. chromatography characterised by constructional or operational features
    • B01D15/18—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to flow patterns
    • B01D15/1864—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to flow patterns using two or more columns
    • B01D15/1871—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to flow patterns using two or more columns placed in series
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/265—Adsorption chromatography
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction
    • B01D15/361—Ion-exchange
    • B01D15/362—Cation-exchange
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction
    • B01D15/361—Ion-exchange
    • B01D15/363—Anion-exchange
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 - B01D15/36
    • B01D15/3804—Affinity chromatography
    • B01D15/3809—Affinity chromatography of the antigen-antibody type, e.g. protein A, G, L chromatography
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/02—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising inorganic material
    • B01J20/20—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising inorganic material comprising free carbon; comprising carbon obtained by carbonising processes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/281—Sorbents specially adapted for preparative, analytical or investigative chromatography
    • B01J20/282—Porous sorbents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J47/00—Ion-exchange processes in general; Apparatus therefor
    • B01J47/014—Ion-exchange processes in general; Apparatus therefor in which the adsorbent properties of the ion-exchanger are involved, e.g. recovery of proteins or other high-molecular compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/20—Partition-, reverse-phase or hydrophobic interaction chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Water Supply & Treatment (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
SG11201807676UA 2016-04-01 2017-03-31 Method for protein purification SG11201807676UA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB201605562 2016-04-01
PCT/EP2017/057685 WO2017167960A1 (fr) 2016-04-01 2017-03-31 Procédé de purification de protéines

Publications (1)

Publication Number Publication Date
SG11201807676UA true SG11201807676UA (en) 2018-10-30

Family

ID=58461345

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201807676UA SG11201807676UA (en) 2016-04-01 2017-03-31 Method for protein purification

Country Status (18)

Country Link
US (1) US11014962B2 (fr)
EP (1) EP3436173A1 (fr)
JP (2) JP7012023B2 (fr)
KR (1) KR102413808B1 (fr)
CN (1) CN108883345B (fr)
AU (1) AU2017242900B2 (fr)
BR (1) BR112018068803A2 (fr)
CA (1) CA3016847C (fr)
CL (1) CL2018002689A1 (fr)
CO (1) CO2018010286A2 (fr)
EA (1) EA201892231A1 (fr)
HK (1) HK1257713A1 (fr)
IL (1) IL261560B (fr)
MX (1) MX2018011435A (fr)
MY (1) MY197993A (fr)
RU (1) RU2737539C2 (fr)
SG (1) SG11201807676UA (fr)
WO (1) WO2017167960A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023136820A1 (fr) * 2022-01-13 2023-07-20 Bayer Healthcare Llc Fabrication d'anticorps améliorée

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5659795A (en) 1979-10-22 1981-05-23 Kanegafuchi Chem Ind Co Ltd Purification of nicotinic acid amide adenine dinucleotide
JP5808249B2 (ja) * 2008-10-20 2015-11-10 アッヴィ・インコーポレイテッド プロテインａアフィニティークロマトグラフィーを用いる抗体の単離および精製
US9096648B2 (en) * 2011-08-19 2015-08-04 Emd Millipore Corporation Methods of reducing level of one or more impurities in a sample during protein purification
SG11201402999UA (en) 2012-03-26 2014-07-30 Emd Millipore Corp Use of charged fluorocarbon compositions in methods for purification of biomolecules
EP2682168A1 (fr) * 2012-07-02 2014-01-08 Millipore Corporation Dispositif de tirage et métier à filer
US9650411B2 (en) * 2012-08-07 2017-05-16 Kyowa Hakko Kirin Co., Ltd. Method of purifying protein
KR102351839B1 (ko) * 2013-03-21 2022-01-18 에보닉 오퍼레이션스 게엠베하 삼중 나선 단백질의 정제
EP3019521A1 (fr) 2013-07-12 2016-05-18 EMD Millipore Corporation Méthode permettant de déterminer si un virus peut être éliminé d'un échantillon contenant une protéine cible à l'aide de charbon actif
JP6141524B2 (ja) 2013-07-12 2017-06-07 メルク パテント ゲーエムベーハー 活性炭を用いた標的タンパク質含有サンプルからのフラグメントの除去
CN104546715B (zh) 2014-12-22 2018-01-16 蓝佳堂生物医药（福建）有限公司 一种用于上呼吸道感染的复合抗体口腔喷剂及其制备方法

Also Published As

Publication number Publication date
JP2019512255A (ja) 2019-05-16
IL261560A (en) 2018-10-31
KR20180131599A (ko) 2018-12-10
US11014962B2 (en) 2021-05-25
CN108883345B (zh) 2022-09-13
CA3016847C (fr) 2023-12-19
CA3016847A1 (fr) 2017-10-05
EP3436173A1 (fr) 2019-02-06
RU2737539C2 (ru) 2020-12-01
WO2017167960A1 (fr) 2017-10-05
MY197993A (en) 2023-07-25
KR102413808B1 (ko) 2022-06-29
HK1257713A1 (zh) 2019-10-25
IL261560B (en) 2021-06-30
RU2018138445A (ru) 2020-05-12
CO2018010286A2 (es) 2018-10-31
JP2022036993A (ja) 2022-03-08
BR112018068803A2 (pt) 2019-01-22
AU2017242900A1 (en) 2018-10-04
AU2017242900B2 (en) 2022-07-28
JP7012023B2 (ja) 2022-01-27
EA201892231A1 (ru) 2019-03-29
MX2018011435A (es) 2019-01-10
US20190153028A1 (en) 2019-05-23
RU2018138445A3 (fr) 2020-07-07
CL2018002689A1 (es) 2018-11-23
CN108883345A (zh) 2018-11-23

Similar Documents

Publication Publication Date Title
SG11201909955XA (en) Formulations of anti-lag3 antibodies and co-formulations of anti-lag3 antibodies and anti-pd-1 antibodies
SG11201908391XA (en) Methods for modulating an immune response
SG11201808724SA (en) Anti-tim-3 antibodies and compositions
SG11201811003PA (en) Anti-pd-l1 antibodies and uses thereof
SG11201808242UA (en) Methods for inhibiting angiogenesis in a subject in need thereof
SG11201807489PA (en) Cells expressing multiple chimeric antigen receptor (car) molecules and uses therefore
SG11201907754RA (en) Anti-phf-tau antibodies and uses thereof
SG11201910134SA (en) Stable formulations of anti-ctla4 antibodies alone and in combination with programmed death receptor 1 (pd-1) antibodies and methods of use thereof
SG11201804803WA (en) Multi-specific antibody molecules having specificity for tnf-alpha, il-17a and il-17f
SG11201809374VA (en) Cd40l-fc fusion polypeptides and methods of use thereof
SG11201906341XA (en) Improved serum albumin binders
SG11201408780XA (en) Optimization of antibodies that bind lymphocyte activation gene-3 (lag-3), and uses thereof
SG11201804673WA (en) Novel anti-claudin antibodies and methods of use
SG11201908056QA (en) Anti-par2 antibodies and uses thereof
SG11201908238SA (en) Anti-c5 antibodies and uses thereof
SG11201403106SA (en) Anti-phf-tau antibodies and their uses
SG11201908326YA (en) Methods of treating neurodegenerative diseases
SG11201806852PA (en) Protein purification
SG11201900845YA (en) Uses of il-13 antagonists for treating atopic dermatitis
SG11201407655TA (en) Therapeutic uses of fibroblast growth factor 21 proteins
SG11201807827VA (en) Process for the preparation of pegylated drug-linkers and intermediates thereof
SG11201907927SA (en) Binding molecules that specifically bind to tau
SG11201900744SA (en) Fc engineered anti-tnfr superfamily member antibodies having enhanced agonistic activity and methods of using them
SG11201901468SA (en) Antibodies with reduced binding to process impurities
SG11201808829VA (en) Tdp-43 mitochondrial localization inhibitor for the treatment of neurodegenerative disease